You have read all your free articles, to continue reading subscribe to read the rest of this content.
Medivir has presented new data from the completed phase Ia study with MIV-818. The primary objective of the phase Ia study was to evaluate safety and tolerability of MIV-818 in liver cancer patients. A total of nine patients with advanced disease were included: six patients with metastatic liver Already a…
Lundbeck recently completed a global Phase IV, randomized, comparative study exploring the role of vortioxetine as a treatment option between SSRIs and serotonin–noradrenaline reuptake inhibitors (SNRIs). The efficacy of vortioxetine was directly compared to one of the latest introduced SNRIs, Already a subscriber Login You have read all your free…
The company announced last week that a major Nordic study will begin using their PET imaging agent ABY-025. ABY-025 is a novel Affibody molecule imaging tracer that can identify HER2 status in breast cancer patients. The researchers will be investigating a new ABY-025 based method developed at UpAlready a subscriber…
Lundbeck and Otsuka report new data from their trials evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder. Data from two global Phase III clinical trials evaluating the safety and efficacy of brexpiprazole for the treatment of patients with manic episodAlready a subscriber Login You have…
